(1)
Patel, D.; John, J.; Bodepudi, R.; Seher, S.; Khan, S.; Emmanuel, S.; Shantha, V.; Nerella, R.; Shaman, B.; Hamid, P. Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in Treatment of Patients With Polycystic Ovary Syndrome: A Systemic Review of Metabolic and Cardiovascular Outcomes. Journal For International Medical Graduates 2024, 3 (1). https://doi.org/10.56570/jimgs.v1i1.149.